Navigating the nuances of the Canadian guideline’s stance on selective serotonin reuptake inhibitors in concurrent alcohol use disorder and mood or anxiety disorders by Elefante, Raymond Julius O., BSN MD, Lu, Clara, MD, Bach, Paxton J., MSc MD

Get full text

Vigilance needed with methamphetamine-associated psychosis by Elefante, Raymond Julius O., MD, Nolan, Seonaid, MD, Bach, Paxton J., MSc MD

Get full text

Avoidance of β-blockers in patients who use stimulants is not supported by good evidence by Wilson, Tyler, MD, Bach, Paxton, MD MSc, Pitcher, Ian, MD

Get full text

Anticraving medication for moderate to severe alcohol use disorder by Mong, Jon, MD, Ahamad, Keith, MD, Bach, Paxton, MD MSc

Get full text

Management of opioid use disorder: 2024 update to the national clinical practice guideline by Yakovenko, Igor, PhD RPsych, Stewart, Sherry H., PhD RPsych, Belliveau, Jacob, BSc, Fraleigh, Ross, BSc, Mukaneza, Yvette, PhD, Germé, Katuschia, PhD, Bach, Paxton, MD MSc, Wood, Evan, MD PhD, Poulin, Ginette, RD MD, Selby, Peter, MBBS MHSc, Rehm, Jürgen, PhD, Goyer, Marie-Ève, MD MSc, Bruneau, Julie, MD MSc, Brothers, Thomas D., MD PhD, Hodgins, David C., PhD RPsych

Get full text

Analyse de la position de la Ligne directrice canadienne sur les inhibiteurs sélectifs du recaptage de la sérotonine dans un contexte de trouble lié à l’usage d’alcool et de troubl... by Elefante, Raymond Julius O., BSN MD, Lu, Clara, MD, Bach, Paxton J., MSc MD

Get full text

L’évitement des β-bloquants chez les patients qui utilisent des stimulants ne repose pas sur des données probantes by Wilson, Tyler, MD, Pitcher, Ian, MD, Bach, Paxton, MD MSc

Get full text

Des médicaments réduisant l’appétence pour l’alcool pour traiter les troubles de consommation d’alcool modérés à graves by Mong, Jon, MD, Ahamad, Keith, MD, Bach, Paxton, MD MSc

Get full text